These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35093894)

  • 1. Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study.
    Gadducci A; Simonetti E; Mezzapesa F; Cosio S; Miccoli M; Frey J; Tintori R; Bulleri A; Neri E
    Anticancer Res; 2022 Feb; 42(2):947-954. PubMed ID: 35093894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
    Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
    Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
    Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer.
    Gadducci A; Cosio S
    Anticancer Res; 2021 Jan; 41(1):9-20. PubMed ID: 33419795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis.
    Jin Y; Ma X; Yang Z; Zhang N
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):697-705. PubMed ID: 36720459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
    Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
    Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
    Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
    Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
    Ubachs J; Koole SN; Lahaye M; Fabris C; Bruijs L; Schagen van Leeuwen J; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham M; van Dam P; Vuylsteke P; Bastings J; Kruitwagen RFPM; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T; Sonke GS; van Driel WJ
    Gynecol Oncol; 2020 Dec; 159(3):706-711. PubMed ID: 33019981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
    Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
    Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
    Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
    Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
    Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia in Advanced Serous Ovarian Cancer.
    Bronger H; Hederich P; Hapfelmeier A; Metz S; Noël PB; Kiechle M; Schmalfeldt B
    Int J Gynecol Cancer; 2017 Feb; 27(2):223-232. PubMed ID: 27870708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy.
    Lee J; Weng CS; Chang CL; Hsu WH; Jan YT; Wu KP
    Support Care Cancer; 2023 Apr; 31(5):267. PubMed ID: 37058264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels.
    Marquardt JP; Roeland EJ; Van Seventer EE; Best TD; Horick NK; Nipp RD; Fintelmann FJ
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):190-202. PubMed ID: 34729952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.
    Kumar A; Moynagh MR; Multinu F; Cliby WA; McGree ME; Weaver AL; Young PM; Bakkum-Gamez JN; Langstraat CL; Dowdy SC; Jatoi A; Mariani A
    Gynecol Oncol; 2016 Aug; 142(2):311-6. PubMed ID: 27235857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.
    Derstine BA; Holcombe SA; Ross BE; Wang NC; Su GL; Wang SC
    Sci Rep; 2018 Jul; 8(1):11369. PubMed ID: 30054580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.